Can we predict long-term survival in resectable pancreatic ductal adenocarcinoma?

OBJECTIVE: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive tumour associated with poor 5-year survival. We aimed to determine factors which differentiate short and long-term survivors and identify a prognostic biomarker. METHODS: Over a ten-year period, patients with resected PDAC who devel...

Descripción completa

Detalles Bibliográficos
Autores principales: Gall, Tamara M.H., Gerrard, Gareth, Frampton, Adam E., Castellano, Leandro, Ahmad, Raida, Habib, Nagy, Spalding, Duncan, Pai, Madhava, Foroni, Letizia, Jiao, Long R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366827/
https://www.ncbi.nlm.nih.gov/pubmed/30774772
http://dx.doi.org/10.18632/oncotarget.26511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366827/
https://www.ncbi.nlm.nih.gov/pubmed/30774772
http://dx.doi.org/10.18632/oncotarget.26511

Ejemplares similares